Wilson Disease Drugs Market 2022-2028

PUBLISHED: January 14, 2023

PAGES:

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Title:Global Wilson Disease Drugs Market Size, Share and Trends Analysis Report, By Drug Type (Chelating Agents, Zinc, and Tetrathiomolybdate), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), Forecast Period (2022-2028).

The global Wilson disease drugs market is expected to grow at a CAGR of 4.5% during the forecast period. The market is primarily driven by increasing awareness regarding Wilson's disease and rising new launches of Wilson disease drugs. According to the World Health Organization (WHO), nearly 29.9% of women aged between 15-49 years suffered from low hemoglobin or anemia, in 2019, which is equivalent to over half a billion women aged 15-49 years. Moreover, in 2019 the global low hemoglobin prevalence was 39.8% in children aged 6-59 months, equivalent to 269 million children with anemia. Wilson is a rare disease that results in copper build-up throughout the body, triggering complications ranging from liver disease to psychiatric conditions. The increasing incidence of low hemoglobin and rising awareness of Wilson's disease across the globe are some factors contributing to the growth of the market.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The European Wilson disease drugs market is driven by the rising focus on patient assistance programs, and the technological advancements that allow early detection of Wilson's disease among patients. The key players in the market are continuously focused on adopting strategic moves such as new product launches. For instance, in August 2021, AstraZeneca announced a late-stage trial of its oral medicine ALXN1480 to treat rare diseases, by removing deposits from tissues compared with standard care. The treatment has been given an 'Orphan Drug' status in the US and European Union to speed up its development.

The major companies operating in the global Wilson disease drugs market include Bausch Health Co. Inc., Nobelpharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., and Kadmon Holdings, Inc. The market players are contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, and new product launches, to stay competitive in the market. For instance, in October 2021, Ultragenyx Pharmaceutical Inc. launched novel products for rare and ultra-rare genetic diseases. The company's AAV9 gene therapy is designed to deliver a stable expression of the ATP7B coper transporter following a single intravenous infusion, to establish normal trafficking of copper in patients with Wilson disease.

Research Methodology

The market study of the global Wilson disease drugs market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

Financial reports of companies involved in the market.

Whitepapers, research papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Wilson Disease Drug Market Research and Analysis by Drug Type
Global Wilson Disease Drug Market Research and Analysis by Route of Administration
Global Wilson Disease Drug Market Research and Analysis by Distribution Channel

The Report Covers:

Comprehensive research methodology of the global Wilson disease drugs market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global Wilson disease drugs market.
Insights about market determinants that are stimulating the global Wilson disease drugs market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2026795

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Recovery Scenario Of Global Wilson Disease Drugs Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight and Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
- 3.1.1. Merck & Co., Inc.
  - 3.1.1.1. Overview
  - 3.1.1.2. Financial Analysis
  - 3.1.1.3. SWOT Analysis
  - 3.1.1.4. Recent Developments
- 3.1.2. Bausch Health Co. Inc.
  - 3.1.2.1. Overview
  - 3.1.2.2. Financial Analysis
  - 3.1.2.3. SWOT Analysis
  - 3.1.2.4. Recent Developments
- 3.1.3. Kadmon Holdings, Inc.
  - 3.1.3.1. Overview
  - 3.1.3.2. Financial Analysis
  - 3.1.3.3. SWOT Analysis
  - 3.1.3.4. Recent Developments
  - 3.1.3.5. Recent Developments
- 3.1.4. Nobelpharma Co. Ltd.
  - 3.1.4.1. Overview
  - 3.1.4.2. Financial Analysis
  - 3.1.4.3. SWOT Analysis
  - 3.1.4.4. Recent Developments
- 3.1.5. Teva Pharmaceutical Industries Ltd.
  - 3.1.5.1. Overview
  - 3.1.5.2. Financial Analysis
  - 3.1.5.3. SWOT Analysis
  - 3.1.5.4. Recent Developments
  - 3.1.5.5. Recent Developments
3.2. Key Strategy Analysis

4. Market Segmentation

4.1. Global Wilson Disease Drugs Market by Drug Type
- 4.1.1. Chelating Agents
- 4.1.2. Zinc
- 4.1.3. Tetrathiomolybdate
4.2. Global Wilson Disease Drugs Market by Route of Administration
- 4.2.1. Oral
- 4.2.2. Parenteral
- 4.2.3. Others
4.3. Global Wilson Disease Drugs Market by Distribution Channel
- 4.3.1. Hospital Pharmacy
- 4.3.2. Retail Pharmacy
- 4.3.3. Others

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. AstraZeneca plc
6.2. Deep Genomics
6.3. DepYmed Inc.
6.4. Dr. Reddy's Laboratories Ltd.
6.5. Lupin Ltd.
6.6. Orphalan SA
6.7. Pfizer Inc.
6.8. Ultragenyx Pharmaceutical Inc.
6.9. Vivet Therapeutics

Product Code: OMR2026795

LIST OF TABLES

1. GLOBAL WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
2. GLOBAL CHELATING AGENTS FOR WILSON DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL ZINC FOR WILSON DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL TETRATHIOMOLYBDATE FOR WILSON DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
6. GLOBAL ORAL WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL PARENTRAL WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL OTHER ROUTE OF ADMINISTRATION FOR WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
10. GLOBAL WILSON DISEASE DRUGS FROM HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL WILSON DISEASE DRUGS FROM RETAIL PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL WILSON DISEASE DRUGS FROM OTHER DISTRIBUTION CHANNELS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. NORTH AMERICAN WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
16. NORTH AMERICAN WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
17. NORTH AMERICAN WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
18. EUROPEAN WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. EUROPEAN WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
20. EUROPEAN WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
21. EUROPEAN WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
22. ASIA-PACIFIC WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. ASIA-PACIFIC WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
26. REST OF THE WORLD WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
27. REST OF THE WORLD WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE , 2021-2028 ($ MILLION)
28. REST OF THE WORLD WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION , 2021-2028 ($ MILLION)
29. REST OF THE WORLD WILSON DISEASE DRUGS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)

LIST OF FIGURES

1. GLOBAL WILSON DISEASE DRUGS MARKET SHARE BY DRUG TYPE, 2021 VS 2028 (%)
2. GLOBAL CHELATING AGENTS FOR WILSON DISEASE MARKET SHARE BY REGION, 2021 VS 2028 (%)
3. GLOBAL ZINC FOR WILSON DISEASE MARKET SHARE BY REGION, 2021 VS 2028 (%)
4. GLOBAL TETRATHIOMOLYBDATE FOR WILSON DISEASE MARKET SHARE BY REGION, 2021 VS 2028 (%)
5. GLOBAL WILSON DISEASE DRUGS MARKET SHARE BY ROUTE OF ADMINISTRATION, 2021 VS 2028 (%)
6. GLOBAL ORAL WILSON DISEASE DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
7. GLOBAL PARENTERAL WILSON DISEASE DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
8. GLOBAL OTHER ROUTE OF ADMINISTRATION FOR WILSON DISEASE DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
9. GLOBAL WILSON DISEASE DRUGS MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
10. GLOBAL WILSON DISEASE DRUGS FROM HOSPITAL PHARMACY MARKET SHARE BY REGION, 2021 VS 2028 (%)
11. GLOBAL WILSON DISEASE DRUGS FROM RETAIL PHARMACY MARKET SHARE BY REGION, 2021 VS 2028 (%)
12. GLOBAL WILSON DISEASE DRUGS FROM OTHER DISTRIBUTION CHANNELS MARKET SHARE BY REGION, 2021 VS 2028 (%)
13. GLOBAL WILSON DISEASE DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
14. US WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
15. CANADA WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
16. UK WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
17. GERMANY WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
18. SPAIN WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
19. FRANCE WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
20. ITALY WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
21. REST OF EUROPE WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
22. INDIA WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
23. CHINA WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
24. JAPAN WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF ASIA-PACIFIC WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF THE WORLD WILSON DISEASE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)